Get startedLog in
    Picture of Medigene AG logo

    MDG1 — Medigene AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Medigene Announces Indication Selection For The Clinical Development Of Lead Therapy Program In Solid Tumors

    Picture of Medigene AG logoMedigene AG
    12/02/2024 13:09
    Feb 12 (Reuters) - Medigene AG  MDG1k.DE :
    * MEDIGENE ANNOUNCES INDICATION SELECTION  FOR THE CLINICAL
DEVELOPMENT OF ITS LEAD 3RD GENERATION TCR-T THERAPY PROGRAM IN
SOLID TUMORS
    * GASTRIC CANCER,OVARIAN CANCER,MYXOID/ROUND CELL
LIPOSARCOMA,SYNOVIAL SARCOMA SELECTED AS INITIAL CLINICAL
INDICATIONS FOR LEAD PROGRAM MDG1015

Source text for Eikon:  ID:nGNXc5Pfpl 
Further company coverage:  MDG1k.DE 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Medigene AG

    See all news